相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Metabolic rewiring in melanoma
B. I. Ratnikov et al.
ONCOGENE (2017)
Thromboxane A2 Receptor Inhibition Suppresses Multiple Myeloma Cell Proliferation by Inducing p38/c-Jun N-terminal Kinase (JNK) Mitogen-activated Protein Kinase ( MAPK)mediated G2/M Progression Delay and Cell Apoptosis
Qian Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Targeting metabolic reprogramming as a potential therapeutic strategy in melanoma
Lorey K. Smith et al.
PHARMACOLOGICAL RESEARCH (2016)
Regulation of NAD biosynthetic enzymes modulates NAD-sensing processes to shape mammalian cell physiology under varying biological cues
Silverio Ruggieri et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2015)
Metabolic reprogramming supports the invasive phenotype in malignant melanoma
Ingrid J. Bettum et al.
CANCER LETTERS (2015)
Physiological and pathophysiological roles of NAMPT and NAD metabolism
Antje Garten et al.
NATURE REVIEWS ENDOCRINOLOGY (2015)
Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer
Deepak Sampath et al.
PHARMACOLOGY & THERAPEUTICS (2015)
NAD+ in aging, metabolism, and neurodegeneration
Eric Verdin
SCIENCE (2015)
Molecular drivers of cellular metabolic reprogramming in melanoma
Cecilie Abildgaard et al.
TRENDS IN MOLECULAR MEDICINE (2015)
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia
Valentina Audrito et al.
BLOOD (2015)
MITF in melanoma: mechanisms behind its expression and activity
Mariusz L. Hartman et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
Cyclin B1/Cdk1 Coordinates Mitochondrial Respiration for Cell-Cycle G2/M Progression
Zhaoqing Wang et al.
DEVELOPMENTAL CELL (2014)
Novel assay for simultaneous measurement of pyridine mononucleotides synthesizing activities allows dissection of the NAD+ biosynthetic machinery in mammalian cells
Federica Zamporlini et al.
FEBS JOURNAL (2014)
Metabolic Profiling of Alternative NAD Biosynthetic Routes in Mouse Tissues
Valerio Mori et al.
PLOS ONE (2014)
Response of BRAF-Mutant Melanoma to BRAF Inhibition Is Mediated by a Network of Transcriptional Regulators of Glycolysis
Tiffany J. Parmenter et al.
CANCER DISCOVERY (2014)
PGC1α Expression Defines a Subset of Human Melanoma Tumors with Increased Mitochondrial Capacity and Resistance to Oxidative Stress
Francisca Vazquez et al.
CANCER CELL (2013)
Oncogenic BRAF Regulates Oxidative Metabolism via PGC1α and MITF
Rizwan Haq et al.
CANCER CELL (2013)
Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors as Therapeutics: Rationales, Controversies, Clinical Experience
By Fabrizio Montecucco et al.
CURRENT DRUG TARGETS (2013)
Pharmacological Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD+ Biosynthesis, in Human Cancer Cells METABOLIC BASIS AND POTENTIAL CLINICAL IMPLICATIONS
Bo Tan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Medicinal Chemistry of Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors
Ubaldina Galli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions
Elena Maldi et al.
PIGMENT CELL & MELANOMA RESEARCH (2013)
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
Axel Hauschild et al.
LANCET (2012)
Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Circumventing Cancer Drug Resistance in the Era of Personalized Medicine
Levi A. Garraway et al.
CANCER DISCOVERY (2012)
The NAD metabolome - a key determinant of cancer cell biology
Alberto Chiarugi et al.
NATURE REVIEWS CANCER (2012)
Noninvasive genomic detection of melanoma
W. Wachsman et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
NAMPT in Regulated NAD Biosynthesis and its Pivotal Role in Human Metabolism
E S. Burgos
CURRENT MEDICINAL CHEMISTRY (2011)
Regulation of melanocyte pivotal transcription factor MITF by some other transcription factors
Ping Wan et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
NF-κB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration
Claudio Mauro et al.
NATURE CELL BIOLOGY (2011)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Regulation of cancer cell metabolism
Rob A. Cairns et al.
NATURE REVIEWS CANCER (2011)
Progressive Activation of CyclinB1-Cdk1 Coordinates Entry to Mitosis
Olivier Gavet et al.
DEVELOPMENTAL CELL (2010)
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
How mitochondria produce reactive oxygen species
Michael P. Murphy
BIOCHEMICAL JOURNAL (2009)
Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity
T. Romacho et al.
DIABETOLOGIA (2009)
Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling -: Implications in the pathogenesis of rheumatoid arthritis
Mari A. Nowell et al.
ARTHRITIS AND RHEUMATISM (2006)
MITF: master regulator of melanocyte development and melanoma oncogene
Carmit Levy et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells
JP Yuan et al.
ONCOGENE (2004)
High frequency of BRAF mutations in nevi
PM Pollock et al.
NATURE GENETICS (2003)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes
S Ognjanovic et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2001)